IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation

American Journal of Pathology

Volumn 184, Issue 7, 2014, Pages 2134-2143

  Ellison, Stephen ^a   Gabunia, Khatuna ^a   Richards, James M ^a   Kelemen, Sheri E ^a   England, Ross N ^a   Rudic, Dan ^b   Azuma, Yasu Taka ^c   Munroy, M Alexandra ^a   Eguchi, Satoru ^a   Autieri, Michael V ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 19; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; IL19 PROTEIN, MOUSE; INTERLEUKIN 10; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY LIGATION; CELL ACTIVATION; CELL ADHESION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; KNOCKOUT MOUSE; MALE; MONOCYTE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; TH2 CELL; VASCULAR SMOOTH MUSCLE; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; CYTOLOGY; HYPERPLASIA; INTIMA; LIGATION; METABOLISM; NEOINTIMA; PATHOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HYPERPLASIA; INTERLEUKIN-10; LIGATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RECOMBINANT PROTEINS; TUNICA INTIMA;

EID: 84903179617     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.001     Document Type: Article

References (31)

1. F.G. Welt, and C. Rogers Inflammation and restenosis in the stent era Arterioscler Thromb Vasc Biol 22 2002 1769 1776
2. G.D. Dangas, B.E. Claessen, A. Caixeta, E.A. Sanidas, G.S. Mintz, and R. Mehran In-stent restenosis in the drug-eluting stent era J Am Coll Cardiol 56 2010 1897 1907
3. M.M. El-Omar, C. Dangas, I. Iakovou, and R. Mehran Update on in-stent restenosis Curr Interv Cardiol Rep 3 2001 296 305
4. R.R. Anis, K.R. Karsch, and M. Oberhoff An update on clinical and pharmacological aspects of drugeluting stents Cardiovasc Hematol Disord Drug Targets 6 2006 245 255
5. L. Slavin, A. Chhabra, and J.M. Tobis Drug-eluting stents: preventing restenosis Cardiol Rev 15 2007 1 12
6. R. Ross The pathogenesis of atherosclerosis: A perspective for the 1990s Nature 362 1993 801 809
7. J. IP, V. Fuster, L. Badimon, J. Badimon, M. Taubman, and J. Chesebro Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
8. R.S. Schwartz, J.G. Murphy, W.D. Edwards, A.R. Camrud, R.E. Vlietstra, and D.R. Holmes Restenosis after balloon angioplasty: A practical proliferative model in porcine coronary arteries Circulation 82 1990 2190 2200
9. G. Gallagher, H. Dickensheets, J. Eskdale, L.S. Izotova, O.V. Mirochnitchenko, J.D. Peat, N. Vazquez, S. Pestka, R.P. Donnelly, and S.V. Kotenko Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) Genes Immun 1 2000 442 450
10. S. Pestka, C.D. Krause, D. Sarkar, M.R. Walter, Y. Shi, and P.B. Fisher Interleukin-10 and related cytokines and receptors Annu Rev Immunol 22 2004 929 979
11. H. Oral, S. Kotenko, M. Yilmaz, O. Mani, J. Zumkehr, K. Blaser, C. Akdis, and M. Akdis Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26 Eur J Immunol 36 2006 380 388
12. G. Gallagher Interleukin-19: multiple roles in immune regulation and disease Cytokine Growth Factor Rev 21 2010 345 352
13. A.A. Cuneo, D. Herrick, and M.V. Autieri IL-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability J Mol Cell Cardiol 49 2010 647 654
14. Y. Tian, L.J. Sommerville, A. Cuneo, S.E. Kelemen, and M.V. Autieri Expression and suppressive effects of interleukin-19 on vascular smooth muscle cell proliferation, signaling, and development of intimal hyperplasia Am J Pathol 173 2008 901 909
15. K. Gabunia, S. Jain, R.N. England, and M.V. Autieri The anti-inflammatory cytokine interleukin-19 inhibits smooth muscle cell migration and activation of cytoskeletal regulators of VSMC motility Am J Physiol Cell Physiol 300 2011 C896 C906
16. D.M. Valenzuela, A.J. Murphy, D. Frendewey, N.W. Gale, A.N. Economides, W. Auerbach, W.T. Poueymirou, N.C. Adams, J. Rojas, J. Yasenchak, R. Chernomorsky, M. Boucher, A.L. Elsasser, L. Esau, J. Zheng, J.A. Griffiths, X. Wang, H. Su, Y. Xue, M.G. Dominguez, I. Noguera, R. Torres, L.E. Macdonald, A.F. Stewart, T.M. DeChiara, and G.D. Yancopoulos High-throughput engineering of the mouse genome coupled with high-resolution expression analysis Nat Biotechnol 21 2003 652 659
17. Y.T. Azuma, Y. Matsuo, M. Kuwamura, G.D. Yancopoulos, D.M. Valenzuela, A.J. Murphy, H. Nakajima, M. Karow, and T. Takeuchi Interleukin-19 protects mice from innate-mediated colonic inflammation Inflamm Bowel Dis 16 2010 1017 1028
18. L.J. Sommerville, S.E. Kelemen, and M.V. Autieri Increased smooth muscle cell activation and neointima formation in response to injury in AIF-1 transgenic mice Arterioscler Thromb Vasc Biol 28 2008 47 53
19. K.J. Harmon, L.L. Couper, and V. Lindner Strain-dependent vascular remodeling phenotypes in inbred mice Am J Pathol 156 2000 1741 1748
20. D.G. Kuhel, B. Zhu, D.P. Witte, and D.Y. Hui Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice Arterioscler Thromb Vasc Biol 22 2002 955 960
21. S. Ellison, K. Gabunia, S.E. Kelemen, R.N. England, R. Scalia, J.M. Richards, W. Orr, J.G. Traylor Jr., T. Rogers, W. Cornwell, L.M. Berglund, I. Goncalves, M.F. Gomez, and M.V. Autieri Attenuation of experimental atherosclerosis by interleukin-19 Arterioscler Thromb Vasc Biol 33 2013 2316 2324
22. A.B. Lyons Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution J Immunol Methods 243 2000 147 154
23. R.N. England, K.J. Preston, R. Scalia, and M.V. Autieri Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability Am J Physiol Cell Physiol 305 2013 C255 C265
24. T. Michigami, N. Shimizu, P.J. Williams, M. Niewolna, S.L. Dallas, G.R. Mundy, and T. Yoneda Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity Blood 96 2000 1953 1960
25. G. Ailawadi, C.W. Moehle, H. Pei, S.P. Walton, Z. Yang, I.L. Kron, C.L. Lau, and G.K. Owens Smooth muscle phenotypic modulation is an early event in aortic aneurysms J Thorac Cardiovasc Surg 138 2009 1392 1399
26. G. Gallagher, J. Eskdale, W. Jordan, J. Peat, J. Campbell, M. Boniotto, G.P. Lennon, H. Dickensheets, and R.P. Donnelly Human interleukin-19 and its receptor: A potential role in the induction of Th2 responses Int Immunopharmacol 4 2004 615 626
27. U. Zeiffer, A. Schober, M. Lietz, E.A. Liehn, W. Erl, N. Emans, Z.Q. Yan, and C. Weber Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines Circ Res 94 2004 776 784
28. J.E. Rectenwald, R.M. Minter, L.L. Moldawer, Z. Abouhamze, D. La Face, E. Hutchins, T.S. Huber, J.M. Seeger, and C.K. Ozaki Interleukin-10 fails to modulate low shear stress-induced neointimal hyperplasia J Surg Res 102 2002 110 118
29. L.J. Feldman, L. Aguirre, M. Ziol, J.P. Bridou, N. Nevo, J.B. Michel, and P.G. Steg Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits Circulation 101 2000 908 916
30. N.D. Brunetti, M. Pepe, I. Munno, F. Tiecco, D. Quagliara, L. De Gennaro, A. Gaglione, M. Di Biase, and S. Favale Th2-dependent cytokine release in patients treated with coronary angioplasty Coron Artery Dis 19 2008 133 137
31. K. Gabunia, S.P. Ellison, H. Singh, P. Datta, S.E. Kelemen, V. Rizzo, and M.V. Autieri Interleukin-19 (IL-19) induces heme oxygenase-1 (HO-1) expression and decreases reactive oxygen species in human vascular smooth muscle cells J Biol Chem 287 2012 2477 2484